Blog

New Medicare Advantage Rule Threatens Beneficiary Choice and Affordability

Read More »

March 20, 2024 No Comments

Bill of the Month — February 2024: The FDA Modernization Act 3.0

Read More »

February 29, 2024 No Comments

TPA Submits Comments on NIST’s Draft March-In Guidance

Read More »

February 7, 2024 No Comments

If Government Must Be Involved With Healthcare, Let There Be Competition

Read More »

January 29, 2024 No Comments

TPA Statement on FDA Approval of Gene Therapies for Sickle Cell Disease

Read More »

December 11, 2023 No Comments

TPA Slams Biden Administration’s Proposed Overreach in Drug Patents

Read More »

December 7, 2023 No Comments

FDA’s Menthol and Cigar Ban is Bad for Consumers and Health

Read More »

November 17, 2023 No Comments

TPA Submits Comments to House Health Care Task Force

Read More »

October 16, 2023 No Comments

Testimony before the Massachusetts Joint Committee on Revenue Regarding the Cigar and Cigarette Tax

Read More »

September 11, 2023 No Comments

TPA to Testify During FDA “Listening Session” on Center for Tobacco Products

Read More »

August 22, 2023 No Comments